Journals / Cukurova Medical Journal / 2013 / Cilt: 38 - Sayı: 1

Synthesis and Antifungal Activity of New Heterocyclic Compounds

Yeni Heterosiklik Bileşiklerin sentezleri ve Antifungal Etkileri

Pages
103–107
Publication Date
2013-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: All synthesized compounds showed significant antifungal activity when compared with ketoconazole.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose:The objective of this study was to describe the synthesis of 2-arylthio-N-(2-methoxydibenzo[b,d]furan-3-yl)acetamide derivatives as heterocyclic compounds and focused on their potential antifungal effects against fungi species.
📊
Key Findings & Data:Method: The reaction of 2-chloro-N-(2-methoxydibenzo[b,d]furan-3-yl)acetamide with various aromatic thiols gave 2-arylthio-N-(2-methoxydibenzo[b,d]furan-3-yl)acetamide derivatives.
💡
Conclusion & Impact:Conclusion: All synthesized compounds showed significant antifungal activity when compared with ketoconazole.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antifungal aktivite · Microbroth dilution method · Dibenzofuran

Abstract

Purpose:The objective of this study was to describe the synthesis of 2-arylthio-N-(2-methoxydibenzo[b,d]furan-3-yl)acetamide derivatives as heterocyclic compounds and focused on their potential antifungal effects against fungi species. Method: The reaction of 2-chloro-N-(2-methoxydibenzo[b,d]furan-3-yl)acetamide with various aromatic thiols gave 2-arylthio-N-(2-methoxydibenzo[b,d]furan-3-yl)acetamide derivatives. Antifungal activities of the synthesized compounds have been evaluated using microbroth dilution method. Results: Four new heterocyclic compounds were synthesized. All compounds were as effective as ketoconazole against T. harzianum, A. ochraceus, C. albicans, whilst the compounds were more effective than ketoconazole against F. solani, F. moniliforme, F. culmorum. Conclusion: All synthesized compounds showed significant antifungal activity when compared with ketoconazole.

Özet

Amaç: Bu çalışmanın amacı, heterosiklik bileşik olarak, 2-ariltiyo-N-(2-metoksidibenzo[b,d]furan-3-il)asetamid türevlerinin sentezleri ve mantar türlerine karşı etkilerini araştırmaktır. Yöntem: 2-Kloro-N-(2-metoksidibenzo[b,d]furan-3-il)asetamid ile uygun aromatik tiyollerin reaksiyonu 2-ariltiyo-N-(2-metoksidibenzo[b,d]furan-3-il)asetamid türevlerini verdi. Sentezlenen bu bileşiklerin antifungal aktiviteleri microbroth dilution method kullanılarak araştırıldı. Bulgular: Dört yeni heterosiklik bileşik sentezlendi. Bileşiklerin tamamı F. solani, F. moniliforme, F. culmorum"a karşı Ketokonazol"den daha aktif çıkarken, C. albicans, T. harzianum, A. ochraceus"e karşı Ketokonazol ile aynı etkiyi göstermiştir. Sonuç: Ketokonazol ile kıyaslandığında, sentezlenen tüm bileşikler önemli derecede antifungal etki göstermişlerdir.

🔖

Cite This Article

KAPLANCIKLI, Z. A., ALTINTOP, M. D., TURAN-ZİTOUNİ, G., ÖZDEMİR, A., DEMİREL, R., MOHSEN, U. A., HUSSEİN, W. (2013). Synthesis and Antifungal Activity of New Heterocyclic Compounds. Cukurova Medical Journal, Cilt: 38 - Sayı: 1, 103–107. https://ajindex.com/articles/57182

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Pfaller MA. The epidemiology of invasive mycosesnarrowing the gap. Clin Infect Dis. 1998; 27:1148-50.
  2. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002; 34:909-17.
  3. Hood S, Denning DW. Treatment of fungal infection in AIDS. J Antimicrob Chemoth. 1996; 37:71-85.
  4. Rees JR, Pinner RW, Hajjeh RA. The epidemiological features of invasive mycotic infections in the San Francisco, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis. 1993; 27:1138-40. Polak A. The past, present and future of antimycotic combination therapy. Mycoses. 1999; 42:355-70.
  5. Musiol R, Jampilek J, Buchta V, Silva L, Niedbala H, Podeszwa B, et al. Antifungal properties of new series of quinolone derivatives. Bioorg Med Chem. 2006; 14:3592-8.
  6. Rao VS, Srinivas K. Modern drug discovery process. J Bioinform Seq Anal. 2011; 2: 89-94.
  7. Ryu CK, Kim YH, Im HA, Kim JY, Yoon JH, Kim A. Synthesis and antifungal activity of 6,7-bis(arylthio)quinazoline-5,8-diones and furo[2,3-f]quinazolin-5ols. Bioorg Med Chem Lett. 2012; 22:500-3.
  8. Ryu CK, Shim JY, Chae MJ, Choi IH, Han JY, Jung OJ, et al. Synthesis and antifungal activity of 2/3arylthio- and 2,3-bis(arylthio)-5-hydroxy-/5-methoxy1,4-naphthoquinones. Eur J Med Chem. 2005; 40:438-44.
  9. Ryu CK, Sun YJ, Shim JY, You HJ, Choi KU, Lee H. Synthesis and antifungal activity of 6,7-bis-[s(aryl)thio]-5,8-quinolinediones. Arc Pharmacal Res. 2002; 25:795-800.
  10. Venkatachalam TK, Barreto J, Kreher U, Reutens DC, Spiccia L. Synthesis, characterization and coordination chemistry of dibenzofuran derivatives of 1,4,7,10-tetraazacyclododecane. Inorg Chim Acta. 2010; 363:2896-904
  11. Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC, et al. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, 6th Ed. Baltimore and Philadelphia, Lippincott Williams & Wilkins, 2006. Espinel-Ingroff A. In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi. J Clin Microbiol. 2001; 39:954 Yaz ışma Adresi / Address for Correspondence: Dr. Zafer Asım Kaplancıklı Anadolu University Graduate Scholl of Health Sciences ESKİŞEHİR e-mail: [email protected]. geliş tarihi/received:11.07.2012 kabul tarihi/accepted:07.09.2012